Dr. Maya Rockeymoore Cummings did not originally set out to build a health technology company. She set out to understand what happened to her husband.
Congressman Elijah Cummings lived for over two decades with thymic carcinoma, a rare cancer that most patients do not survive for long. Through an NIH clinical trial, he became one of the longest surviving patients with the disease, managing it as a chronic condition rather than a death sentence.
But another condition also worked against him: hypertension. For years, Elijah was treated with a medication that did not match what his specific health profile required. As a result, he struggled with blood pressure control for much of his adult life. It was not until he saw the late Dr. Elijah Saunders, a legendary Johns Hopkins cardiologist who spent his career studying hypertension in Black men, that the gap became clear. Dr. Saunders explained that Black men often need a specific three-drug combination to bring blood pressure under control, information that was documented in the medical literature but had not been applied to Elijah’s care. By the time his treatment was corrected, the damage could not be reversed.
Elijah Cummings died on October 17, 2019, at the age of 68, following a cascade of interrelated health complications. Even as his body struggled, he kept serving his constituents and kept showing up for his community.
More than a year before he died, Elijah and Maya drove several hours from Baltimore to Virginia to pick out a miniature labradoodle. He told her plainly that he would not always be there, and that he wanted her to have both a companion and an early warning system against intruders in the house for her safety. That dog was named Andy.
After Elijah’s death, during the isolation of the pandemic, Maya began reading about what artificial intelligence was starting to do in healthcare: synthesizing biomarker data, behavioral patterns, and social context in real time to flag risk before disease escalated. One question stayed with her: what if a system like that had existed for Elijah?
That question sharpened at a February 2024 Johns Hopkins University panel Maya moderated on disparities in hypertension, cardiovascular disease, and stroke. Physicians on the panel discussed how genetics, environment, and social determinants intersect (one summarized it simply: genetics loads the gun, environment pulls the trigger) and how Black and Latino patients often move through the stages of cardiometabolic risk earlier in life, driven less by biology than by the compounding weight of social and environmental stressors. When a panelist raised implicit bias and therapeutic inertia (physicians being slower to intensify treatment even when the evidence calls for it) as reasons nearly half of hypertension cases go uncontrolled, Maya asked the question that would not leave her alone: how might AI and technology help with that? One physician on the panel called it the million dollar question.
HyperVigilant is Maya’s answer. Healosphere, the company’s AI platform for cardiometabolic health, is built to do what the healthcare system did not do for Elijah: monitor health signals continuously, adapt guidance to a person’s specific biological and cultural context, and connect patients with their clinicians and caregivers before small gaps become irreversible harm.
At the center of the platform is ANDI, an AI health agent designed to be an early warning system against disease threats named after Andy, the dog Elijah chose so Maya would not be alone.
In Maya’s words:
“Elijah Cummings was failed by a healthcare system that moved too slowly, coordinated too poorly, and knew too little about what a Black man’s body specifically needed. He was not an outlier. He was not uniquely unlucky. What happened to him happens every day, to millions of people who have far less access, far fewer resources, and far less visibility than a United States Congressman.
He kept going anyway. He served anyway. He loved anyway.
The least I can do is build the system that should have been there for him, and make sure it is there for everyone who comes after.”
